Back to search results

Feasibility of High Intensity Interval Training for Hodgkin Lymphoma Survivors

This study is looking at whether a 12-week High Intensity Interval Training (HIIT) program is practical and safe for young people who have survived Hodgkin lymphoma. HIIT involves short bursts of intense exercise followed by recovery periods. You might be able to join if you are between 10 and 25 years old, were diagnosed with Hodgkin lymphoma between those ages, and finished your treatment within the last 24 months. The study wants to see how many eligible people join and how many complete the exercise sessions and follow-up tests. This is a small study aiming to enroll 20 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention (HIIT). It is a small study planning to enroll 20 participants.
What's involved
You would participate in a 12-week HIIT program with three 25-minute sessions per week. You would also have baseline and post-intervention assessments, including exercise testing, body composition, and blood tests.
Compensation
Not stated in the trial record.
Follow-up
The primary goals of the study are measured at the completion of the 12-week program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07222345

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

Recruiting
NAAges 10–25InterventionalSupportive care
St. Jude Children's Research Hospital
~20 participants
Updated 2026-06-10 on ClinicalTrials.gov
What's tested:High Intensity Interval Training (HIIT)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participation rate (percent of eligible participants approached who enroll)
Measured over Trial completion (12 weeks)
+1 more outcome measured

Conditions

Hodgkin Lymphoma

Explore related trials

Hodgkin's Granuloma

NCT07222345

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • St. Jude Children's Research Hospital

    Memphis, Tennesseestudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Amy Berkman, MD · PRINCIPAL_INVESTIGATOR · St. Jude Children's Research Hospital

Who to contact

Amy Berkman, MD
[email protected]
888-226-4343
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant has been diagnosed with Hodgkin lymphoma between the ages of 10 to 25 years.
Participant is between the ages of \>10 and \<25 years old the time of enrollment.
Participant has completed treatment (end of chemotherapy for those not receiving radiation therapy or end of radiation therapy) for Hodgkin lymphoma within 24 months prior to enrollment and recovered from any acute treatment-related adverse events.
Participant has been medically cleared to participate in physical activity.
Participant verbalizes understanding of directions for use of the web-based platform on the study provided iPad and heart rate monitor.

Exclusion

Participant has evidence of relapsed disease.
Participant has a diagnosis of acute heart failure.
Participant reports currently participating in HIIT training or \>420 minutes per week of moderate to vigorous physical activity.
Female participant who is currently pregnant.

What this trial measures

  • Participation rate (percent of eligible participants approached who enroll)Trial completion (12 weeks)

    Descriptive statistics will be reported

  • Completion rate (percentage of scheduled HIIT sessions attended and percentage of post-intervention testing sessions completed)Trial completion (12 weeks)

    Descriptive statistics will be reported